- 期刊
Novel Antiplatelet Agent Use for Acute Coronary Syndrome in the Emergency Department: A Review
延伸閱讀
- Caruso, R., Rocchiccioli, S., Gori, A. M., Cecchettini, A., Giusti, B., Parodi, G., Cozzi, L., Marcucci, R., Parolini, M., Romagnuolo, I., Citti, L., Abbate, R., & Parodi, O. (2015). Inflammatory and Antioxidant Pattern Unbalance in \"Clopidogrel-Resistant\" Patients during Acute Coronary Syndrome. Mediators of Inflammation, 2015(), 682-693-370. https://doi.org/10.1155/2015/710123
- Lin, C. F. (2012). Effectiveness and Risk of Pharmacotherapy in Patients with Acute Coronary Syndrome [doctoral dissertation, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU.2012.01289
- Hsu, C. L., Lin, Y. S., Lin, W. H., Kuo, L. Y., & Huang, H. Y. (2014). Survival of Patients with Acute Coronary Syndrome who Receive Secondary Prevention Therapy: A Single-center Cohort Study. 物理治療, 39(4), 223-230. https://doi.org/10.6215/FJPT.PTS1396504715
- 戴笠修（2021）。The association between use of dual antiplatelet agent with and without concurrent medication and the risk in the patient who had coronary artery disease after percutaneous coronary intervention〔碩士論文，中山醫學大學〕。華藝線上圖書館。https://doi.org/10.6834/csmu202100119
- Chang, H. Y., Hsu, L. W., Lee, C. H., Lin, C. C., Huang, C. W., Chen, P. W., Yang, P. K., Hsueh, Y. C., & Liu, P. Y. (2019). Impact of Platelet Volume on the Clinical Outcomes of Patients with Acute Coronary Syndrome. Acta Cardiologica Sinica, 35(6), 563-570. https://doi.org/10.6515/ACS.201911_35(6).20190423B